URINARY TRACT INFECTIONS
Clinical trials for URINARY TRACT INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new URINARY TRACT INFECTIONS trials appear
Sign up with your email to follow new studies for URINARY TRACT INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New UTI vaccine enters human trials – could it stop recurrent infections?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine designed to prevent urinary tract infections (UTIs) caused by E. coli bacteria. About 448 adults aged 18–64 will take part, with a focus on safety and immune response in all participants, and early signs of effectiveness in women. The vaccine is giv…
Matched conditions: URINARY TRACT INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 15:15 UTC
-
Virus cocktail takes on superbug UTIs
Disease control Recruiting nowThis study tests a new treatment called LBP-EC01, made from viruses that attack bacteria, for urinary tract infections (UTIs) caused by drug-resistant E. coli. About 318 adults with a history of UTIs will receive either LBP-EC01 plus an antibiotic or a placebo plus an antibiotic.…
Matched conditions: URINARY TRACT INFECTIONS
Phase: PHASE2 • Sponsor: Locus Biosciences • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Probiotic pill vs antibiotic: which stops repeat UTIs better?
Disease control Recruiting nowThis study tests two approaches to prevent repeat bladder infections in women after menopause. One group takes a nightly antibiotic for 6 months; the other uses a vaginal tablet containing good bacteria and a low-dose hormone. The goal is to see which method better prevents infec…
Matched conditions: URINARY TRACT INFECTIONS
Phase: PHASE4 • Sponsor: Mahidol University • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New DNA test could speed up UTI diagnosis and treatment
Diagnosis Recruiting nowThis study compares a new DNA-based test (DNA PCR) to the standard urine culture for diagnosing urinary tract infections (UTIs) in adults. Participants with UTI symptoms will be randomly assigned to one of the two testing methods. The goal is to see if the DNA test leads to faste…
Matched conditions: URINARY TRACT INFECTIONS
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Diagnosis
Last updated Apr 30, 2026 15:51 UTC
-
One shot, no pills: new study tests quick UTI fix in ER
Symptom relief Recruiting nowThis study looks at whether a single injection of the antibiotic amikacin can effectively treat uncomplicated bladder infections (UTIs) in women visiting the emergency department. Instead of taking pills for several days, participants get one shot into a muscle or vein. The goal …
Matched conditions: URINARY TRACT INFECTIONS
Sponsor: Antonios Likourezos • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
New model aims to cut unnecessary antibiotics for UTIs in the ER
Knowledge-focused Recruiting nowThis study looks at whether a prediction model can help reduce unnecessary antibiotic use for urinary tract infections (UTIs) in the emergency room. About 47 women diagnosed with a UTI and sent home with antibiotics will be included. The goal is to see if the model can safely gui…
Matched conditions: URINARY TRACT INFECTIONS
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Study tests if scheduled Follow-Up calls beat waiting for parents to call back
Knowledge-focused Recruiting nowThis study looks at whether scheduling automatic follow-up appointments after a child leaves the hospital works better than letting parents decide when to call. About 2,674 children hospitalized for infections like pneumonia or urinary tract infections will take part. The goal is…
Matched conditions: URINARY TRACT INFECTIONS
Phase: NA • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
New antibiotic candidate JKN2501 begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called JKN2501 in 66 healthy adults to see if it is safe and how the body processes it. The drug is being developed to fight bacterial infections like urinary tract and lung infections. Participants will receive either the drug or a pl…
Matched conditions: URINARY TRACT INFECTIONS
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC